Market revenue in 2023 | USD 906.9 million |
Market revenue in 2030 | USD 1,116.7 million |
Growth rate | 3% (CAGR from 2023 to 2030) |
Largest segment | Fecal occult blood tests |
Fastest growing segment | Biomarker tests |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fecal Occult Blood Tests, Biomarker tests, CRC DNA Screening Tests |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro colorectal cancer screening tests market will help companies and investors design strategic landscapes.
fecal occult blood tests was the largest segment with a revenue share of 81.65% in 2023. Horizon Databook has segmented the Global in-vitro colorectal cancer screening tests market based on fecal occult blood tests, biomarker tests, crc dna screening tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global in-vitro colorectal cancer screening tests market , including forecasts for subscribers. This global databook contains high-level insights into Global in-vitro colorectal cancer screening tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account